Effective Public Health Approaches to Reducing Congenital Syphilis astho, association of state and territorial health officials, provider bias, syphilis screening requirements, medicaid family planning programs, medicaid eligibility, congenital syphilis, musculoskeletal defects, pregnant people, public health, trans men, medicaid family planning, gender identity, early congenital syphilis, tested for syphilis, neutral terms, blood test, musculoskeletal system, inclusive language, reproductive health, medicaid coverage, transgender and nonbinary people, medicaid programs, family planning benefits, birth control, carpal tunnel syndrome, musculoskeletal disorders, treponema pallidum, gender neutral language, health care Julia Greenspan, Alex Kearly, Rachel Scheckman, JoAnne McClure, Sanaa Akbarali Effective Public Health Approaches to Reducing Congenital Syphilis Rates of congenital syphilis (CS)—when an infant contracts the disease during pregnancy or birth—are continuing to climb at an alarming rate in the United States. Although preventable, rates more than tripled between 2017 and 2021, with more than 2,800 cases reported in 2021 alone. CS can cause stillbirth, infant death, or other serious and permanent complications including musculoskeletal defects (e.g., impairments in the muscles, bones, and joints leading to temporary or lifelong limitations in functioning), vision and hearing problems, and developmental delays. An ASTHO technical package is a summary of a select group of related interventions that, taken together, help achieve and sustain improvements related to risk factors or health outcomes. ASTHO technical packages are based on programmatic subject matter experts' assessment of evidence-based interventions, expert recommendations, overviews of current activities, and a review of CDC and other federal funding guidance. They are not intended to be comprehensive and can be iterative. ASTHO’s Congenital Syphilis Technical Package focuses on policy-level interventions that states and territories can pursue starting in pregnancy. ASTHO acknowledges other evidence-based or promising policy interventions that broadly address sexually transmitted disease (STI) prevention that are not reflected in this technical package. Further, this technical package will be updated when updates to CDCs guidance on recommended syphilis screening for pregnant persons are available. A summary of ASTHO’s Congenital Syphilis Technical Package is outlined in the this table. Increase Universal Screenings for Pregnant Persons Testing pregnant people for syphilis at three points of pregnancy—first and third trimesters and at delivery—is an evidence-based approach to reduce CS. The American College of Obstetricians and Gynecologists and CDC currently recommend universal first trimester screening and additional screening for those who are at risk or live in areas of high rates of syphilis. However, these screening recommendations rely on providers’ knowledge of the epidemiology in their area and to take patient histories to accurately judge risk. Additionally, jurisdictions may have other laws or recommendations that reflect variability in testing requirements. Jurisdictions can increase syphilis screening of pregnant people by modifying their laws to require screening at three points during pregnancy. They can do so through direct authority of state health officials, Medicaid, state medical licensing boards, and other enforcement mechanisms. How Public Health can Leverage Medicaid to Reduce CS Rates Medicaid provides coverage for low-income adults nationwide and covers more than 40% of all births. Syphilis rates are nearly six times higher among women insured through Medicaid compared to women insured through commercial insurance. Optimize Medicaid Eligibility, Services, and Providers for At-Risk Pregnant People and their Partners States can expand eligibility for Medicaid Family Planning Programs, which provide family planning benefits and STI services to people who would not otherwise qualify. In most states, services are available for individuals up to 200% Federal Poverty Level (FPL). Some states (e.g., Iowa) are expanding eligibility beyond that threshold. Additionally, implementing State Plan Amendments (SPA) to expand Medicaid postpartum coverage can allow coverage of postpartum treatment for syphilis. States can work with Medicaid agency partners to ensure Medicaid services comprehensively cover STI testing, treatment, and counseling with minimal cost-sharing. States can also submit 1115 waivers to cover unmet health-related social needs, or HRSN services (e.g., housing, nutrition, transportation), that exacerbate poor health outcomes and should be addressed in tandem with medical treatment. Further, states can weigh in on Medicaid managed care organizations (MCO) contract requirements to ensure coverage of HRSN services. States can leverage alternative provider types, such as community health workers (CHWs), doulas, and perinatal case managers to facilitate access to services, encourage first and third trimester STI screenings, and provide support services. Currently, nine states and Washington D.C. reimburse doula services under Medicaid. CHWs are already providing services for people living with HIV and can perform a variety of roles, improving access to care for people with syphilis. They can help with care coordination, coaching, providing social support and health education. S/THAs can work with their Medicaid agency partners to submit an SPA or 1115 waiver to cover CHWs, doulas or perinatal case managers, or create managed care requirements to require use of these provider types. Incentivize Providers to Comply with Universal Syphilis Screening Requirements S/THAs can work with Medicaid agency partners to adopt and incentivize the Prenatal and Postpartum Care CMS Core Measure (National Committee for Quality Assurance Measure #1517) as part of the state’s quality strategy. Incentivizing the quality measure encourages providers to meet performance metrics through a financial incentive. Further, states can update practice guidelines to encourage providers to conduct universal STI screenings during prenatal care visits, including syphilis testing in the first and third trimester. S/THAs can work with their Medicaid agency partners and MCOs to develop additional provider incentives. For example, AmeriHealth Caritas—a Louisiana-based MCO—offers provider incentives for third trimester syphilis testing. The performance is measured based on the percent of live deliveries that had at least one test for syphilis. Practices that score above the 55th percentile for third trimester screenings are eligible for bonus payments. States can also partner with their Medicaid agency partners and incentivize consumers through MCOs. Several states offer incentive programs for pregnant persons who attend one or all prenatal appointments. For example, Kentucky offers gift cards and South Carolina offers items such as strollers or car seats. Establish an Implementation Plan for the Quality Strategy S/THAs can work with their Medicaid agency partners to develop consumer education materials, including information on how to enroll in Medicaid, covered services, provider availability, and how to reduce the risk of CS. Targeted enrollment outreach to pregnant persons in their first trimester is critical for early testing and treatment since being screened for syphilis is more likely if a person is enrolled in Medicaid earlier. S/THAs can also work with their Medicaid agency partners and MCOs to ensure Medicaid providers are aware of quality measure changes and how to leverage incentive payments by including information through communication materials including Medicaid provider bulletins and state quality strategies. Establish Cross-Agency Collaboration and Governance Structures A critical step in ensuring implementation of payment incentives and legislation is creating mechanisms for S/THAs and their state Medicaid agencies to better coordinate services and polices directed toward low-income individuals at risk for CS and other syndemic conditions. Strategies for cross-agency collaboration and governance could include: Establishing a joint Medicaid/public health quality committee related to syndemics (e.g., CS and/or HIV). Creating a standing policy body that has a designated position for OB/GYN physician leaders to advise and engage in practice change. Building relationships and engaging with Medicaid quality committees to highlight public health data, policy, best practice, and support available to respond to the rise in cases. Remove Barriers to Care by Addressing Stigma and Provider Bias Removing barriers to screening and treatment and addressing stigma and implicit bias are critical to reducing CS rates. Structural racism and prejudice contribute to and reinforce disparities in maternal and neonatal morbidity and mortality, including rates of CS. To address stigma, policymakers must implement strategies that address systematic prejudice and discrimination including developing systems that have several points of entry for care, provide culturally competent training for the providers and perinatal workforce, and fostering multi-sector referral relationships. Additionally, leveraging the perinatal workforce, including doulas, can support pregnant and postpartum people in seeking and remaining in prenatal and postnatal care. Doulas act as advocates and educators for pregnant people and using them improves maternal and neonatal outcomes. To increase access to doulas, states should consider expanding doula coverage under Medicaid. Medicaid reimbursement of doula services—which are typically covered out-of-pocket—helps make their services available to low-income and underserved populations. Blog - ASTHO's Congenital Syphilis Technical Package Conclusion States and territories can address the rise in CS infections by focusing on